Trial intelligence / Profile preview

Predictors of Outcome for SIJ Injection

NCT06684938Completed

Sponsor
Alexandria University
Start
May 2023
Primary completion
Nov 2024
Countries
1
01

Overview

Open-label, single-arm trial of corticosteroids in sacroiliac joint dysfunction, sponsored by Alexandria University. Primary endpoints: Postinjection Sacroiliac Pain Intensity at 3 months and Postinjection Disability Questionnaire at 3 months. Started May 2023; status: completed.

02

Drugs

corticosteroids
03

Conditions

sacroiliac joint dysfunction

Beyond the preview

Go deeper on NCT06684938.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06684938.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call